This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Learn more here.

FULC Insider Trading

Insider Ownership Percentage: 2.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $695.10

Fulcrum Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Fulcrum Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fulcrum Therapeutics Share Price & Price History

Current Price: $9.60
Price Change: Price Increase of +0.05 (0.52%)
As of 02/23/2024 01:00 AM ET

This chart shows the closing price history over time for FULC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Free Stock Analysis Report: See The True Value of Any Stock
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Analyze Any Stock Free

Fulcrum Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/10/2023Greg TourangeauInsiderSell210$3.31$695.1015,992View SEC Filing Icon  
1/20/2023Ra Capital Management, L.P.Major ShareholderBuy1,923,076$13.00$24,999,988.0011,609,704View SEC Filing Icon  
1/13/2023Robert J. GouldCEOSell6,766$15.00$101,490.00499,864View SEC Filing Icon  
1/4/2023Ra Capital Management, L.P.Major ShareholderBuy180,703$7.28$1,315,517.849,686,628View SEC Filing Icon  
12/27/2022Ra Capital Management, L.P.Major ShareholderBuy4,089$5.99$24,493.119,505,925View SEC Filing Icon  
12/19/2022Ra Capital Management, L.P.Major ShareholderBuy98,787$5.90$582,843.309,501,836View SEC Filing Icon  
12/16/2022Ra Capital Management, L.P.Major ShareholderBuy1,341,420$5.42$7,270,496.409,403,049View SEC Filing Icon  
12/14/2022Ra Capital Management, L.P.Major ShareholderBuy824,600$5.46$4,502,316.007,824,600View SEC Filing Icon  
6/6/2022Robert J. GouldDirectorSell24,382$8.10$197,494.20506,630View SEC Filing Icon  
6/3/2022Robert J. GouldDirectorSell25,551$7.95$203,130.45506,630View SEC Filing Icon  
4/7/2022Robert J. GouldDirectorSell5,631$24.02$135,256.62506,630View SEC Filing Icon  
4/4/2022Robert J. GouldDirectorSell7,235$24.02$173,784.70506,630View SEC Filing Icon  
4/1/2022Robert J. GouldDirectorSell34,464$24.03$828,169.92506,630View SEC Filing Icon  
6/28/2021Christopher MorabitoInsiderBuy1,100$9.16$10,076.001,100View SEC Filing Icon  
6/28/2021Curtis Gale OltmansSVPBuy1,088$9.01$9,802.881,088View SEC Filing Icon  
6/28/2021James A. GeraghtyDirectorBuy10,000$9.16$91,600.0090,714View SEC Filing Icon  
6/28/2021Peter G ThomsonVPBuy2,300$9.00$20,700.00View SEC Filing Icon  
3/15/2021Robert J. GouldInsiderSell9,211$12.13$111,729.43507,419View SEC Filing Icon  
See Full Table
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Learn more here.

SEC Filings (Institutional Ownership Changes) for Fulcrum Therapeutics (NASDAQ:FULC)

89.83% of Fulcrum Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FULC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Fulcrum Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024Barclays PLC68,185$0.46M0.0%N/A0.110%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.2,519,984$17.01M0.0%-4.7%4.076%Search for SEC Filing on Google Icon
2/15/2024Opaleye Management Inc.130,000$0.88M0.2%N/A0.210%Search for SEC Filing on Google Icon
2/14/2024ADAR1 Capital Management LLC637,405$4.30M1.5%N/A1.031%Search for SEC Filing on Google Icon
2/14/2024LM Advisors LLC16,132$0.11M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/14/2024Balyasny Asset Management L.P.105,179$0.71M0.0%N/A0.170%Search for SEC Filing on Google Icon
2/14/2024Vestal Point Capital LP1,025,000$6.92M0.7%N/A1.658%Search for SEC Filing on Google Icon
2/14/2024RTW Investments LP5,469,956$36.92M0.6%-6.0%8.848%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp144,965$0.98M0.0%+1.4%0.234%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 3,658$25K0.0%-30.3%0.006%Search for SEC Filing on Google Icon
2/13/2024Affinity Asset Advisors LLC125,000$0.84M0.2%N/A0.202%Search for SEC Filing on Google Icon
2/13/2024Goldman Sachs Group Inc.871,503$5.88M0.0%+236.2%1.410%Search for SEC Filing on Google Icon
2/12/2024Capstone Investment Advisors LLC10,000$68K0.0%N/A0.016%Search for SEC Filing on Google Icon
2/12/2024Stifel Financial Corp71,455$0.48M0.0%+158.1%0.116%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.24,821$0.17M0.0%-12.5%0.040%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG30,183$0.20M0.0%+170.5%0.049%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP975,279$6.58M0.0%+73.5%1.578%Search for SEC Filing on Google Icon
1/31/2024abrdn plc256,888$1.73M0.0%N/A0.416%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.7,150$48K0.0%+348.6%0.012%Search for SEC Filing on Google Icon
1/19/2024Denali Advisors LLC57,800$0.39M0.1%-18.1%0.093%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.2,643,195$11.74M0.0%+0.7%4.276%Search for SEC Filing on Google Icon
12/7/2023Hudson Bay Capital Management LP196,488$0.87M0.0%N/A0.318%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.89,189$0.40M0.0%+1,028.5%0.144%Search for SEC Filing on Google Icon
11/30/2023American Century Companies Inc.36,939$0.16M0.0%+30.0%0.060%Search for SEC Filing on Google Icon
11/22/2023Graham Capital Management L.P.11,845$53K0.0%-62.9%0.019%Search for SEC Filing on Google Icon
11/17/2023Jacobs Levy Equity Management Inc.265,506$1.18M0.0%N/A0.429%Search for SEC Filing on Google Icon
11/15/2023RTW Investments LP5,818,804$25.84M0.5%-4.0%9.412%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.2,406,422$10.69M0.0%+4.3%3.893%Search for SEC Filing on Google Icon
11/14/2023Brown Wealth Management LLC25,000$0.11M0.1%N/A0.040%Search for SEC Filing on Google Icon
11/14/2023Qube Research & Technologies Ltd13,066$58K0.0%N/A0.021%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC31,010$0.14M0.0%N/A0.050%Search for SEC Filing on Google Icon
11/13/2023ClariVest Asset Management LLC104,400$0.46M0.0%N/A0.169%Search for SEC Filing on Google Icon
11/13/2023FMR LLC5,975,416$26.53M0.0%+7.6%9.666%Search for SEC Filing on Google Icon
11/13/2023DekaBank Deutsche Girozentrale60,000$0.27M0.0%N/A0.097%Search for SEC Filing on Google Icon
11/9/2023Cowen AND Company LLC4,308,359$19.13M1.3%+38.2%6.969%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.89,189$0.40M0.0%+1,028.5%0.144%Search for SEC Filing on Google Icon
11/9/2023UBS Group AG11,157$50K0.0%-64.9%0.018%Search for SEC Filing on Google Icon
11/8/2023Vivo Capital LLC520,000$2.31M0.3%-5.5%0.841%Search for SEC Filing on Google Icon
11/8/2023Landscape Capital Management L.L.C.28,252$0.13M0.0%N/A0.046%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC91,790$0.41M0.0%N/A0.148%Search for SEC Filing on Google Icon
10/20/2023Denali Advisors LLC70,600$0.31M0.1%N/A0.114%Search for SEC Filing on Google Icon
8/15/2023Woodline Partners LP596,695$1.97M0.0%N/A0.965%Search for SEC Filing on Google Icon
8/15/2023XTX Topco Ltd83,166$0.27M0.0%-32.8%0.135%Search for SEC Filing on Google Icon
8/15/2023Y Intercept Hong Kong Ltd61,587$0.20M0.0%+107.6%0.100%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.387,732$1.28M0.0%+30.2%0.627%Search for SEC Filing on Google Icon
8/15/2023DRW Securities LLC11,000$36K0.0%N/A0.018%Search for SEC Filing on Google Icon
8/15/2023Point72 Asset Management L.P.1,899,968$6.27M0.0%-28.1%3.073%Search for SEC Filing on Google Icon
8/15/2023Point72 Middle East FZE32,145$0.11M0.0%+645.7%0.052%Search for SEC Filing on Google Icon
8/15/2023RBF Capital LLC154,100$0.51M0.0%N/A0.249%Search for SEC Filing on Google Icon
8/15/2023Stifel Financial Corp25,488$84K0.0%-25.3%0.041%Search for SEC Filing on Google Icon
8/15/2023Suvretta Capital Management LLC5,718,881$18.87M1.0%+10.5%9.251%Search for SEC Filing on Google Icon
8/14/2023Ergoteles LLC40,800$0.14M0.0%N/A0.066%Search for SEC Filing on Google Icon
8/14/2023Tower Research Capital LLC TRC 11,020$36K0.0%+86.1%0.018%Search for SEC Filing on Google Icon
8/14/2023Marshall Wace LLP17,400$57K0.0%-85.6%0.028%Search for SEC Filing on Google Icon
8/14/2023State of Wisconsin Investment Board117,000$0.39M0.0%+23.5%0.189%Search for SEC Filing on Google Icon
8/14/2023State Street Corp205,947$0.68M0.0%-78.7%0.333%Search for SEC Filing on Google Icon
8/14/2023Prelude Capital Management LLC11,171$37K0.0%N/A0.018%Search for SEC Filing on Google Icon
8/14/2023Graham Capital Management L.P.31,948$0.11M0.0%-78.3%0.052%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC344,810$1.14M0.0%-11.6%0.558%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.1,514,425$5M0.0%-63.8%2.450%Search for SEC Filing on Google Icon
8/11/2023MYDA Advisors LLC50,000$0.17M0.0%N/A0.081%Search for SEC Filing on Google Icon
8/11/2023Harvard Management Co. Inc.341,972$1.13M0.1%-16.7%0.553%Search for SEC Filing on Google Icon
8/11/2023Franklin Resources Inc.28,356$94K0.0%N/A0.046%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC565,809$1.87M0.0%-46.8%0.915%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp143,427$0.47M0.0%-68.3%0.232%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.24,485$81K0.0%-82.7%0.040%Search for SEC Filing on Google Icon
8/10/2023Tekla Capital Management LLC256,888$0.85M0.0%+338.8%0.416%Search for SEC Filing on Google Icon
8/10/2023Citigroup Inc.7,903$26K0.0%+362.2%0.013%Search for SEC Filing on Google Icon
8/9/2023Dimensional Fund Advisors LP475,335$1.57M0.0%-37.0%0.769%Search for SEC Filing on Google Icon
8/7/2023Cowen AND Company LLC3,116,996$10.29M0.9%+43.2%5.042%Search for SEC Filing on Google Icon
8/7/2023Mirabella Financial Services LLP32,760$0.11M0.0%N/A0.053%Search for SEC Filing on Google Icon
8/3/2023Barclays PLC144,983$0.48M0.0%+432.0%0.235%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp62,322$0.21M0.0%-70.6%0.101%Search for SEC Filing on Google Icon
7/28/2023Marquette Asset Management LLC27,867$92K0.0%N/A0.045%Search for SEC Filing on Google Icon
5/26/2023ProShare Advisors LLC10,347$29K0.0%N/A0.017%Search for SEC Filing on Google Icon
5/18/2023JPMorgan Chase & Co.190,269$0.54M0.0%+3.0%0.308%Search for SEC Filing on Google Icon
5/16/2023Susquehanna Fundamental Investments LLC41,534$0.12M0.0%-50.9%0.067%Search for SEC Filing on Google Icon
5/16/2023State Street Corp965,588$2.75M0.0%+23.7%1.563%Search for SEC Filing on Google Icon
5/16/2023Squarepoint Ops LLC319,711$0.91M0.0%N/A0.518%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC1,062,634$3.03M0.0%+24.2%1.721%Search for SEC Filing on Google Icon
5/16/2023Graham Capital Management L.P.146,979$0.42M0.0%+588.3%0.238%Search for SEC Filing on Google Icon
5/16/2023Alyeska Investment Group L.P.152,148$0.43M0.0%N/A0.246%Search for SEC Filing on Google Icon
5/15/2023Cubist Systematic Strategies LLC65,076$0.19M0.0%+112.0%0.105%Search for SEC Filing on Google Icon
5/15/2023Suvretta Capital Management LLC5,177,710$14.76M0.6%+21.1%8.384%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Advisers LP262,600$0.75M0.0%+310.3%0.425%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP649,810$1.85M0.0%+388.5%1.052%Search for SEC Filing on Google Icon
5/15/2023Deutsche Bank AG31,733$90K0.0%+69.1%0.051%Search for SEC Filing on Google Icon
5/15/2023Price T Rowe Associates Inc. MD36,461$0.10M0.0%-75.8%0.059%Search for SEC Filing on Google Icon
5/15/2023RTW Investments LP5,511,839$15.71M0.3%+10.4%8.925%Search for SEC Filing on Google Icon
5/15/2023XTX Topco Ltd123,768$0.35M0.1%+254.8%0.200%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC390,100$1.11M0.0%N/A0.632%Search for SEC Filing on Google Icon
5/12/2023Candriam S.C.A.101,337$0.27M0.0%N/A0.164%Search for SEC Filing on Google Icon
5/12/2023BlackRock Inc.4,183,738$11.92M0.0%+28.0%6.774%Search for SEC Filing on Google Icon
5/12/2023Bank of America Corp DE42,370$0.12M0.0%-26.5%0.069%Search for SEC Filing on Google Icon
5/12/2023Dimensional Fund Advisors LP754,886$2.15M0.0%+95.1%1.222%Search for SEC Filing on Google Icon
5/12/2023Charles Schwab Investment Management Inc.141,311$0.40M0.0%+23.0%0.229%Search for SEC Filing on Google Icon
5/12/2023ProShare Advisors LLC10,347$29K0.0%N/A0.017%Search for SEC Filing on Google Icon
5/11/2023Cornercap Investment Counsel Inc.44,078$0.13M0.0%+26.3%0.071%Search for SEC Filing on Google Icon
5/11/2023FMR LLC6,156,328$17.55M0.0%+17.6%9.968%Search for SEC Filing on Google Icon
5/11/2023American Century Companies Inc.20,203$57K0.0%N/A0.033%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Fulcrum Therapeutics logo
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy is under phase III clinical trial; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia is under phase I clinical trial. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has collaboration and license agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and MyoKardia, Inc. to discover, develop, and commercialize novel targeted therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Read More on Fulcrum Therapeutics

Today's Range

Now: $9.60
Low: $9.43
High: $9.76

50 Day Range

MA: $7.59
Low: $5.50
High: $9.64

52 Week Range

Now: $9.60
Low: $2.25
High: $9.90

Volume

341,215 shs

Average Volume

594,998 shs

Market Capitalization

$593.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.25

Who are the company insiders with the largest holdings of Fulcrum Therapeutics?

Fulcrum Therapeutics' top insider investors include:
  1. Ra Capital Management, LP (Major Shareholder)
  2. Robert J Gould (Director)
  3. Robert J Gould (CEO)
  4. Greg Tourangeau (Insider)
Learn More about top insider investors at Fulcrum Therapeutics.

Who are the major institutional investors of Fulcrum Therapeutics?

Fulcrum Therapeutics' top institutional shareholders include:
  1. RTW Investments LP — 8.85%
  2. Vanguard Group Inc. — 4.08%
  3. Vestal Point Capital LP — 1.66%
  4. Dimensional Fund Advisors LP — 1.58%
  5. Goldman Sachs Group Inc. — 1.41%
  6. ADAR1 Capital Management LLC — 1.03%
Learn More about top institutional investors of Fulcrum Therapeutics stock.

Which major investors are selling Fulcrum Therapeutics stock?

Within the previous quarter, FULC stock was sold by these institutional investors:
  1. RTW Investments LP
  2. Vanguard Group Inc.
  3. Simplex Trading LLC
  4. Denali Advisors LLC
  5. Citadel Advisors LLC
  6. Franklin Resources Inc.
  7. Tower Research Capital LLC TRC

Which major investors are buying Fulcrum Therapeutics stock?

During the previous quarter, FULC stock was purchased by institutional investors including:
  1. Vestal Point Capital LP
  2. ADAR1 Capital Management LLC
  3. Goldman Sachs Group Inc.
  4. Dimensional Fund Advisors LP
  5. abrdn plc
  6. Opaleye Management Inc.
  7. Affinity Asset Advisors LLC
  8. Balyasny Asset Management L.P.
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Learn more here.